Hunter C. Smith, Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 11,676 shares at $102.66 ($1.2M) on 2026-02-10, disclosed to the SEC on 2026-02-12.
Seasonal sale ($1.2M) by Chief Financial Officer — this insider has traded RYTM in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $102.66 | 1,913 | $196K | 16.7% |
| 2 | $102.66 | 1,913 | $196K | 16.7% |
| 3 | $103.68 | 700 | $73K | 6.2% |
| 4 | $103.68 | 700 | $73K | 6.2% |
| 5 | $104.76 | 100 | $10K | 0.9% |
| 6 | $98.37 | 2,266 |
| $223K |
| 19.0% |
| 7 | $99.44 | 400 | $40K | 3.4% |
| 8 | $99.44 | 400 | $40K | 3.4% |
| 9 | $100.85 | 100 | $10K | 0.9% |
| 10 | $100.85 | 100 | $10K | 0.9% |
| 11 | $96.26 | 292 | $28K | 2.4% |
| 12 | $96.26 | 292 | $28K | 2.4% |
| 13 | $97.67 | 400 | $39K | 3.3% |
| 14 | $97.67 | 400 | $39K | 3.3% |
| 15 | $98.99 | 800 | $79K | 6.7% |
| 16 | $98.99 | 800 | $79K | 6.7% |
| 17 | $100.10 | 100 | $10K | 0.9% |
| Total | $100.53 avg | 11,676 | $1.2M | 100% |
| Filing → |
| RYTM | SELL | 2026-02-06 | $1.4M | — | Filing → |
| RYTM | SELL | 2025-08-14 | $5.1M | — | Filing → |
| RYTM | SELL | 2025-07-11 | $4.8M | — | Filing → |